Introduction
Cardiomyopathy encompasses a broad spectrum of cardiac conditions that arise from the abnormalities or impairment associated with the heart muscle cells. Heart muscle cells are medically known by the term cardiac myocytes. The cardiac musculature helps the heart maintain the systemic blood flow through the different heart chambers. These muscles enable the heart to squeeze its chambers upon receiving appropriate impulses. This squeezing or compression expresses the blood out of the heart, providing access to the systemic circulation.
What Is Hypertrophic Cardiomyopathy?
Hypertrophic cardiomyopathy is a specific ailment involving the heart muscles that develops inborn. Most often, it is reported to have a familial inheritance pattern. In hypertrophic cardiomyopathy, there is abnormal augmentation and magnification in the heart's muscle cell growth. This aberration in the growth pattern of muscle cells impacts the structure and function of the heart. As a result of added growth, these muscle cells make the heart wall sturdy and chunky, eventually compromising the ability of the heart chambers to elicit more muscular contractions.
There are two distinct types of hypertrophic cardiomyopathy: nonobstructive and obstructive hypertrophic cardiomyopathy. In nonobstructive, despite the abnormal muscle cell augmentation, the outflow of blood from the cardiac chamber remains unimpeded. In the obstructive type, there will be evident and appreciable hindrances to the driving out of blood from the lower left cardiac chamber (left ventricle).
What Is Hypertrophic Cardiomyopathy With Midventricular Obstruction?
Hypertrophic cardiomyopathy with midventricular obstruction is quite an infrequent, obstructive cardiac condition. It is considered to be a subtype of hypertrophic cardiomyopathy with appreciable hindrance to the flow of blood. This condition develops specifically on the left ventricle and is an asymmetric form of cardiomyopathy. It is also regarded as midventricular obstructive hypertrophic cardiomyopathy. Contrary to the typical obstructive form of hypertrophic cardiomyopathy, hypertrophic cardiomyopathy with midventricular obstruction hinders intraventricular (inside the ventricle) blood flow. In contrast, the outflow of blood from the heart remains relatively stable. It is reported that the condition tends to advance with aging.
What Leads to the Development of Hypertrophic Cardiomyopathy With Midventricular Obstruction?
The development of hypertrophic cardiomyopathy with midventricular obstruction is more or less linked with the aberration in the genes concerned with ruling cardiac myocytes. The genetic modulation (gene mutation) that develops during the intrauterine (within the womb) stage is identified to be the etiology behind this inborn condition. There is a set of gene mutations that are recognized to be able to precipitate this cardiac condition. Aberration in any of these genes reflects anatomical and structural variations in the heart's chambers. In hypertrophic cardiomyopathy with midventricular obstruction, an exaggerated enlargement of the cardiomyocytes is identified in the left ventricle, more focused on the middle portion of the ventricle, producing an intra-cavitary blockage at the middle segment.
What Are the Clinical Manifestations Associated With Hypertrophic Cardiomyopathy With Midventricular Obstruction?
There is an array of manifestations elicited by individuals with hypertrophic cardiomyopathy with midventricular obstruction. These manifestations are more individualized and differ slightly in accordance with the involved gene. At times, the condition may remain occult without flagging apparent manifestations. Such cases are often detected accidentally while performing diagnostic tests for other illnesses and conditions. Some of the routinely reported manifestations of hypertrophic cardiomyopathy with midventricular obstruction include the following:
-
Angina: The person may occasionally experience pain and discomfort in and around the chest region. Strenuous physical activities or exercises often trigger angina.
-
Dyspnea: The person may elicit short breaths, and often, the individual cannot breathe in a satisfactory amount of air. There will be a remarkable compromise in the inspired air.
-
Presyncope: It is quite a disturbing state of body and mind, where the person encounters symptoms of passing out and collapse. In presyncope, the person often experiences graying out of vision and gets drenched in sweat, but the person remains aware and awake, unlike in syncope. However, at times, the person may collapse while performing strenuous activities.
-
Weakness: The person often feels exhausted and worn out. There will be a marked compromise in the performance output of the affected person.
-
Palpitation: The aberrant function of the cardiomyocytes contributes to raced heart beating, medically called palpitation. Raced beating is often coupled with an unorganized and arrhythmic heart beating, leading to the development of arrhythmias.
How Is Hypertrophic Cardiomyopathy With Midventricular Obstruction Diagnosed?
The detection of hypertrophic cardiomyopathy with midventricular obstruction is often achieved with the help of various cardiac diagnostic interventions. Clinical manifestation and comprehensive medical history aid in the path of diagnosis. However, diagnostic interventions pave the way for the final diagnosis. Some of the widely preferred cardiac diagnostic measures for the detection of hypertrophic cardiomyopathy with midventricular obstruction include:
-
Echocardiography: Here, sound waves are employed to picture the internal structure of the heart to the extent that even the heart wall thicknesses and its dimensions can be easily assessed with the help of echocardiography. In addition, it also offers a clear visualization of the muscular hindrance within the ventricle.
-
Cardiac Magnetic Resonance Imaging: It extends a more comprehensive cardiac structure and function evaluation. It helps the doctors determine the exact orientation and severity of the muscular obstruction in the ventricle. Hourglass configuration of the left ventricle is a hallmark finding of hypertrophic cardiomyopathy with midventricular obstruction, which can be accentuated with the help of cardiac magnetic resonance imaging techniques.
-
Electrocardiogram: As the name implies, it evaluates the heart's electrical processes and activities. Hypertrophic cardiomyopathy with mid-ventricular obstruction-induced conduction errors can be detected and analyzed with the help of an electrocardiogram.
-
Gene Test: It provides an idea about the alteration in the gene expression, which in turn helps to spotlight the genetic factor that has evoked this cardiac abnormality.
-
Cardiac Catheterization: It is quite an extensive and exploratory form of cardiac diagnostic intervention. It detects the pressure gradient within the left ventricle on either side of the midventricular obstruction. It is not a routinely advised technique. However, when other techniques fail to bring out fruitful findings concerning diagnosing hypertrophic cardiomyopathy with midventricular obstruction, it is advised as a choice.
How Is Hypertrophic Cardiomyopathy With Midventricular Obstruction Treated?
The treatment strategy for hypertrophic cardiomyopathy with midventricular obstruction is designed by considering the extent and severity of the obstruction and the person's general well-being. Conservative and surgical approaches are used to deal with the condition's manifestations. The Conservative approach encompasses pharmacological interventions (beta or calcium channel blockers) and lifestyle alterations. For patients with palpable manifestations, surgical treatment is advised where the muscular obstruction will be surgically relieved by opening up the obstruction across the left ventricle. Associated heart conditions, if any, should also be dealt with appropriate treatment modalities.
Conclusion
Hypertrophic cardiomyopathy with midventricular obstruction is an atypical form of cardiac condition, where the exaggerated cardiac muscle growth gives rise to the formation of septal extension (composed of muscle cells) that hinders the blood flow within the left ventricular chamber. This establishes a pressure gradient across the hindrance, which remarkably impairs the normal functioning of the heart. A minor degree of obstruction can be tackled with conservative approaches. However, periodic monitoring is essential to track disease advancement. The prompt treatment strategies enhance the patient's quality of life and extend longevity.
